Does RISANKIZUMAB-RZAA Cause Arthropathy? 294 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 294 reports of Arthropathy have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
294
Reports of Arthropathy with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
1
Deaths
49
Hospitalizations
How Dangerous Is Arthropathy From RISANKIZUMAB-RZAA?
Of the 294 reports, 1 (0.3%) resulted in death, 49 (16.7%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Arthropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 294 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Arthropathy?
ETANERCEPT (11,842)
ADALIMUMAB (11,670)
ABATACEPT (11,099)
METHOTREXATE (10,973)
TOCILIZUMAB (9,816)
LEFLUNOMIDE (9,277)
HYDROXYCHLOROQUINE (8,770)
RITUXIMAB (8,619)
INFLIXIMAB (8,410)
SULFASALAZINE (7,545)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Arthropathy Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA